-- 
Redhill Biopharma Gains Second Day on Diagnostic Test Purchase

-- B y   S u s a n   L e r n e r
-- 
2011-09-20T08:18:51Z

-- http://www.bloomberg.com/news/2011-09-20/redhill-biopharma-gains-second-day-on-diagnostic-test-purchase.html
Redhill Biopharma Ltd. soared for a
second day after the Israeli biopharmaceutical company said
yesterday it agreed to buy the rights to a diagnostic test to
help identify a bacteria connected to Crohnâ€™s disease.  The shares jumped 9.8 percent to 2.43 shekels as of 11:01
a.m. in  Tel Aviv , bringing the two-day gain to 30 percent, the
biggest such increase since the stock started trading in
February.  To contact the reporter on this story:
Susan Lerner in Jerusalem at 
 slerner2@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  